Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
3
×
springworks therapeutics
10x genomics
dihydroergotamine
glaxosmithkline
medical device
nirogacestat
pfizer
raleigh-durham blog main
raleigh-durham top stories
abbvie
acute migrane
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
bain capital
bausch health
biogen
biotech ipos
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
brian kaspar
bristol-myers squibb
cadent therapeutics
What
biotech
3
×
companies
days
ipo
satsuma
springworks
activity
august
bio
boost
busy
decisions
devices
dog
drug
drugs
fda
firm
followed
genomics
hasn’t
haul
ipos
leading
led
legacy
life
line
markets
migraine
news
nods
opioid
past
pfizer
place
prep
public
regulatory
roundup
Language
unset
3
×
Current search:
biotech
×
unset
×
" satsuma pharmaceuticals "
×
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
